US3012964A
(en)
|
1958-06-24 |
1961-12-12 |
Universal Oil Prod Co |
Hydrocarbon oil composition
|
US3022077A
(en)
|
1958-09-15 |
1962-02-20 |
Doonan William |
Arrowhead construction
|
JP2610889B2
(ja)
|
1987-09-03 |
1997-05-14 |
日本臓器製薬株式会社 |
新規架橋アデニン誘導体
|
US6028076A
(en)
|
1996-07-03 |
2000-02-22 |
Japan Energy Corporation |
Purine derivative
|
PL332040A1
(en)
|
1996-08-28 |
1999-08-16 |
Pfizer |
Substitution 6,5-heterobicyclic derivatives
|
WO1998014448A1
(fr)
|
1996-10-04 |
1998-04-09 |
Kyorin Pharmaceutical Co., Ltd. |
Derives de pyrazolopyridylpyridazinone et procede de preparation des ces derniers
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6339089B2
(en)
|
1997-08-13 |
2002-01-15 |
Fujirebio Inc. |
Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
|
EP1035123B1
(en)
|
1997-11-28 |
2003-08-20 |
Sumitomo Pharmaceuticals Company, Limited |
Novel heterocyclic compounds
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
WO1999041253A1
(en)
|
1998-02-17 |
1999-08-19 |
Tularik Inc. |
Anti-viral pyrimidine derivatives
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
JP4315300B2
(ja)
|
1998-08-10 |
2009-08-19 |
大日本住友製薬株式会社 |
新規なキナゾリン誘導体
|
JP4342007B2
(ja)
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
CA2341707C
(en)
|
1998-08-27 |
2010-02-16 |
Sumitomo Pharmaceuticals Co., Ltd. |
Pyrimidine derivatives
|
US6583148B1
(en)
|
1999-04-08 |
2003-06-24 |
Krenitsky Pharmaceuticals, Inc. |
Neurotrophic substituted pyrimidines
|
US6503908B1
(en)
|
1999-10-11 |
2003-01-07 |
Pfizer Inc |
Pharmaceutically active compounds
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
AU2002364211A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
TW200407143A
(en)
|
2002-05-21 |
2004-05-16 |
Bristol Myers Squibb Co |
Pyrrolotriazinone compounds and their use to treat diseases
|
EP1552842A1
(en)
|
2002-06-07 |
2005-07-13 |
Kyowa Hakko Kogyo Co., Ltd. |
Bicyclic pyrimidine derivatives
|
BR0314761A
(pt)
|
2002-09-27 |
2005-07-26 |
Sumitomo Pharma |
Composto de adenina e seu uso
|
US8455458B2
(en)
|
2002-10-16 |
2013-06-04 |
Arthrodynamic Technologies, Animal Health Division, Inc. |
Composition and method for treating connective tissue damage
|
KR20060016817A
(ko)
|
2003-06-20 |
2006-02-22 |
콜리 파마슈티칼 게엠베하 |
소분자 톨-유사 수용체 (tlr) 길항제
|
OA13310A
(en)
|
2003-09-05 |
2007-04-13 |
Anadys Pharmaceuticals Inc |
TLR7 ligands for the treatment of hepatitis C.
|
WO2005092892A1
(ja)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
8−オキソアデニン化合物
|
WO2005092893A1
(ja)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
9置換−8−オキソアデニン化合物
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
EP1797050B1
(en)
|
2004-08-10 |
2013-10-23 |
Janssen Pharmaceutica NV |
Hiv inhibiting 1.2.4-triazin-6-one derivates
|
AU2005304040B2
(en)
|
2004-11-09 |
2009-04-23 |
F. Hoffmann-La Roche Ag |
Aminoquinazolines compounds
|
US7498409B2
(en)
|
2005-03-24 |
2009-03-03 |
Schering Corporation |
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
|
BRPI0611435A2
(pt)
|
2005-05-04 |
2010-09-08 |
Pfizer Ltd |
derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos
|
MX2007013715A
(es)
|
2005-05-05 |
2008-01-28 |
Ardea Biosciences Inc |
Diaril-purinas, azapurinas y deazapurinas como inhibidores no nucleosidos de transcriptasa inversa para el tratamiento del virus de inmunodeficiencia humana.
|
TW200716631A
(en)
|
2005-05-12 |
2007-05-01 |
Tibotec Pharm Ltd |
Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
|
US7994360B2
(en)
|
2005-05-16 |
2011-08-09 |
Xtl Biopharmaceuticals Ltd. |
Benzofuran compounds
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
JP4850911B2
(ja)
|
2005-09-01 |
2012-01-11 |
エフ.ホフマン−ラ ロシュ アーゲー |
P2x3およびp2x2/3モジュレーターとしてのジアミノピリミジン
|
US20090192153A1
(en)
|
2005-09-22 |
2009-07-30 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
WO2007056208A2
(en)
|
2005-11-02 |
2007-05-18 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
WO2007063934A1
(ja)
|
2005-12-02 |
2007-06-07 |
Mitsubishi Tanabe Pharma Corporation |
脂環式複素環化合物
|
BRPI0707945A2
(pt)
|
2006-02-17 |
2011-05-17 |
Pfizer Ltd |
derivados de 3-deazapurina como modulares de tlr7
|
US9259426B2
(en)
|
2006-07-20 |
2016-02-16 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
US8673929B2
(en)
|
2006-07-20 |
2014-03-18 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
JP5500990B2
(ja)
|
2006-12-07 |
2014-05-21 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ホスホイノシチド3−キナーゼ阻害剤化合物及び使用方法
|
EP2121707B1
(en)
|
2006-12-20 |
2012-12-05 |
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. |
Antiviral indoles
|
PT2510946E
(pt)
|
2007-02-07 |
2015-11-23 |
Univ California |
Conjugados de agonistas sintéticos de tlr e suas utilizações
|
JP2008222557A
(ja)
|
2007-03-08 |
2008-09-25 |
Kotobuki Seiyaku Kk |
ピロロ[3,2−d]ピリミジン誘導体及びこれを有効成分とする医薬組成物
|
JP5480637B2
(ja)
|
2007-03-19 |
2014-04-23 |
アストラゼネカ・アクチエボラーグ |
Toll様受容体(tlr7)モジュレーターとしての9−置換−8−オキソ−アデニン化合物
|
WO2008114819A1
(ja)
|
2007-03-20 |
2008-09-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
EP2152674B1
(en)
|
2007-05-22 |
2011-08-03 |
Boehringer Ingelheim International GmbH |
Benzimidazolone chymase inhibitors
|
KR101561710B1
(ko)
|
2007-06-29 |
2015-10-19 |
길리애드 사이언시즈, 인코포레이티드 |
퓨린 유도체 및 그것의 톨 유사 수용체 7의 조절 인자로서 용도
|
AU2008287421A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
MX2010002336A
(es)
|
2007-08-28 |
2010-03-25 |
Irm Llc |
Derivados de 2-bifenil-amino-4-amino-pirimidina como inhibidores de cinasa.
|
WO2009030998A1
(en)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Pyrimidine compounds as toll-like receptor (tlr) agonists
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
EP2238142B1
(en)
|
2007-12-24 |
2012-07-04 |
Janssen R&D Ireland |
Macrocyclic indoles as hepatitis c virus inhibitors
|
EP2259788A4
(en)
|
2008-02-07 |
2011-03-16 |
Univ California |
TREATMENT OF BLADDER DISEASES WITH A TLR7 ACTIVATOR
|
WO2009134624A1
(en)
|
2008-04-28 |
2009-11-05 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
DK2313111T3
(da)
|
2008-08-01 |
2013-12-02 |
Ventirx Pharmaceuticals Inc |
Toll-lignende receptoragonistformuleringer og anvendelse deraf
|
CA2760766A1
(en)
|
2009-05-21 |
2010-11-25 |
Nicholas James Bennett |
Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
US20120232062A1
(en)
|
2009-10-20 |
2012-09-13 |
Eiger Biopharmaceuticals, Inc. |
Azaindazoles to treat flaviviridae virus infection
|
IN2012DN02984A
(lt)
|
2009-10-22 |
2015-07-31 |
Gilead Sciences Inc |
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
WO2012045089A2
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Methods for the treatment of allergic diseases
|
WO2012066335A1
(en)
|
2010-11-19 |
2012-05-24 |
Astrazeneca Ab |
Phenol compounds als toll -like receptor 7 agonists
|
WO2012067269A1
(en)
|
2010-11-19 |
2012-05-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Aminoalkoxyphenyl compounds and their use in the treatment of disease
|
KR102058946B1
(ko)
|
2011-04-08 |
2019-12-24 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염 치료를 위한 피리미딘 유도체
|
BR112013029537B1
(pt)
*
|
2011-05-18 |
2020-06-30 |
Janssen Sciences Ireland Uc |
derivados de quinazolina, seu uso no tratamento de infecções virais e outras doenças e composição farmacêutica que os compreende
|
IN2014MN00862A
(lt)
|
2011-11-09 |
2015-04-17 |
Janssen R & D Ireland |
|
BR112014019699B1
(pt)
|
2012-02-08 |
2021-12-07 |
Janssen Sciences Ireland Uc |
Derivados de piperidino-pirimidina, seu uso no tratamento de infecções virais e composição farmacêutica que os compreende
|
EP2841428B1
(en)
|
2012-04-24 |
2018-08-22 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
UA113651C2
(xx)
|
2012-07-13 |
2017-02-27 |
|
Макроциклічні пурини для лікування вірусних інфекцій
|
EA029266B1
(ru)
|
2012-08-10 |
2018-02-28 |
Янссен Сайенсиз Айрлэнд Юси |
Алкилпиримидиновые производные для лечения вирусных инфекций
|
TW201920090A
(zh)
|
2012-08-28 |
2019-06-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
胺磺醯基-芳醯胺類及其做為治療b型肝炎之醫藥劑的用途
|
EP2712866A1
(en)
|
2012-10-01 |
2014-04-02 |
Centre National de la Recherche Scientifique (CNRS) |
1,2,4-triazine derivatives for the treatment of viral infections
|
JP6283033B2
(ja)
|
2012-10-05 |
2018-02-21 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症およびさらなる疾患の処置のためのアシルアミノピリミジン誘導体
|
DK2906563T3
(en)
|
2012-10-10 |
2018-06-06 |
Janssen Sciences Ireland Uc |
PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR TREATING VIRUS INFECTIONS AND OTHER DISEASES
|
PL2925729T3
(pl)
|
2012-11-16 |
2018-04-30 |
Janssen Sciences Ireland Uc |
Heterocykliczne podstawione pochodne 2-amino-chinazoliny do leczenia infekcji wirusowych
|
BR112015020118B1
(pt)
|
2013-02-21 |
2022-02-22 |
Janssen Sciences Ireland Uc |
Derivados de 2-aminopirimidina para o tratamento de infecções virais, composição farmacêutica e uso
|
HUE031908T2
(en)
|
2013-03-29 |
2017-08-28 |
Janssen Sciences Ireland Uc |
Macrocyclic deaza-purinones for the treatment of viral infections
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
US10377738B2
(en)
|
2013-05-24 |
2019-08-13 |
Janssen Sciences Ireland Unlimited Company |
Pyridone derivatives for the treatment of viral infections and further diseases
|
BR112015032546B1
(pt)
*
|
2013-06-27 |
2022-05-17 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina e composição farmacêutica que os compreende para o tratamento de infecções virais e outras doenças
|
EA036162B1
(ru)
*
|
2013-07-30 |
2020-10-08 |
Янссен Сайенсиз Айрлэнд Юси |
Производные тиено[3,2-d]пиримидинов для лечения вирусных инфекций
|
EP3166938A4
(en)
|
2014-07-11 |
2018-01-17 |
Northwestern University |
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase
|
CU20180011A7
(es)
|
2015-03-04 |
2018-06-05 |
Gilead Sciences Inc |
Composiciones farmacéuticas que comprenden compuestos derivados de diaminopirido (3,2-d) como moduladores de receptor de tipo toll
|
AR107633A1
(es)
|
2016-02-19 |
2018-05-16 |
Hoffmann La Roche |
Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico
|
CA3021068A1
(en)
|
2016-04-15 |
2017-10-19 |
Novira Therapeutics, Inc. |
Combinations and methods comprising a capsid assembly inhibitor
|
MA45539A
(fr)
*
|
2016-07-01 |
2019-05-08 |
Janssen Sciences Ireland Unlimited Co |
Dihydropyranopyrimidines pour le traitement d'infections virales
|
CA3035346A1
(en)
*
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|